Please make JavaScript on and see this site.
Jump to body
HOME
日本語
Site map
Contact us
Font size
Standard
Large
日本語
Menu
Close
Favorite pages
Search
Safety Alert & Recalls/ Review Reports/ Package Inserts etc.
Formats DL
Menu of each service
Menu for each of you
Menu of each product type
Back
Reviews and Related Services
Outline
Consultations
Reviews
GLP / GCP / GPSP Compliance Assessments
GMP / QMS / GCTP Inspections
Assessments to Registered Certification Bodies
Regulatory Information
Public comments
Post-marketing Safety Measures
Outline
Scientific Research and Analyses
Provision of Information regarding Post-marketing Safety
Regulatory Information
Public comments
Relief Services for Adverse Health Effects
Outline
Public comments
Regulatory Science/The Science Board/Standard Development
Outline
Recent Publications by PMDA Staff
Regulatory Science Research in PMDA
Projects Across Multi-Offices in PMDA
Outline
The Science Board
Subcommittees
Outline
Japanese Pharmacopoeia
Medical Device Standards
International Activities
Outline
International Harmonization
Cooperation with International Organizations
Bilateral Arrangements
Cooperation with Asia
Asia Training Center
Overseas Office
Public comments
Back
For Regulatory Authorities
Regulations & Services of PMDA
Training Seminar
Reviews
Safety Measures - Outline
Safety Measures - RMP
Relief Services for Adverse Health Effects
GLP / GCP / GPSP Compliance Assessments
GMP / QMS / GCTP Inspections
Japanese Pharmacopeia
Medical Device Standards
Information about Approved Products in Japan
New Drugs
New Medical Devices
International Activities
PMDA International Strategic Plan
PMDA International Vision
Road map for the PMDA International Vision
Safety Information
The Yellow Letter / Blue Letter
Revisions of PRECAUTIONS
PMDA Alert for Proper Use of Drugs
PMDA Medical Safety Information
Advanced Efforts
Science Board
Office of Advanced Evaluation with Electronic Data
Strategy of SAKIGAKE by MHLW
Projects Across Multi-Offices in PMDA
FAQ
Frequently Asked Questions (FAQ)
For Healthcare Professionals
Information for approved products in Japan
Drugs
Medical Devices
Regenerative Medical Products
Safety information
The Yellow Letter / Blue Letter
Revisions of Drug Package Inserts
PMDA Alert for Proper Use of Drugs
PMDA Medical Safety Information
FAQ
Frequently Asked Questions (FAQ)
For Academia
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Outline of Reviews and Related Services
Consultations
Japanese Pharmacopoeia
Medical Device Standards
Companion Diagnostics
Information for approved products in Japan
Drugs
Medical Devices
Regenerative Medical Products
Regulatory science
The Science Board
FAQ
Frequently Asked Questions (FAQ)
For Business
Regulations and services of PMDA
Reviews
Safety Measures - Outline
Safety Measures - RMP
GLP / GCP / GPSP Compliance Assessments
GMP / QMS / GCTP Inspections
Japanese Pharmacopeia
Medical Device Standards
Information for approved products in Japan
New Drugs
New Medical Devices
Procedures in Japan
Master File System
Accreditation of Foreign Manufacturers
Advanced efforts
Science Board
Office of Advanced Evaluation with Electronic Data
Strategy of SAKIGAKE by MHLW
Projects Across Multi-Offices in PMDA
FAQ
Frequently Asked Questions (FAQ)
Back
Drugs
Regulations and Services of PMDA
Reviews
Safety Measures
Relief Services for Adverse Health Effects
Japanese Pharmacopoeia
Information for apporoved products in Japan
New drugs
Safety information
The Yellow Letter / Bule Letter
Revisions of drug package inserts
PMDA Alert for Proper Use of Drugs
PMDA Medical Safety Information
Procedures in Japan
Master File System
Accreditation of Foreign Manufacturers
Advanced efforts
Science Board
Subcommittee on Placebo-controlled Studies
Subcommittee on Non-clinical Studies
Pharmaceuticals Subcommittee
Bio-products Subcommittee
Advanced Review with Electronic Data Promotion Group
Strategy of SAKIGAKE by MHLW
Projects Across Multi-Offices in PMDA
Medical devices
Regulations and Services of PMDA
Reviews
Safety Measures
Medical Device Standards
Information for apporoved products in Japan
New devices
Safety information
PMDA Medical Safety Information
Procedures in Japan
Accreditation of Foreign Manufacturers
Advanced efforts
Science Board
Subcommittee on Evaluation of Medical Devices in Pediatric Use
Subcommittee on Application of Numerical Analysis to Non-clinical Evaluation
Medical Devices Subcommittee
Quasi-drugs
Reviews and Related Services
Outline of Reviews and Related Services
GMP
Regulatory Procedures
Accreditation of Foreign Manufacturers
Post-marketing Safety Measures
Outline of Post-marketing Safety Measures
Regenerative medical products
Reviews and Related Services
Outline of Reviews and Related Services
Information for Approved Products
Post-marketing Safety
Measures
Outline of Post-marketing Safety Measures
Advanced Efforts
CPC (Cell Processing Center) Subcommittee
Cellular and Tissue-based Products Subcommittee
Home
日本語
Site Map
Contact Us
Home
Contact Us
E-mail Form
Contact Us
E-mail Form
Add this page to "Favorite pages"
Print the text
Last name (required)
First name (required)
Title
Dr.
Mr.
Ms.
E-mail (required)
Sender`s business (required)
Regulatory authority
Industry
Media
Academia (university/institute)
Other organizations
Individuals
Others
Name of organization/department (required)
Country (required)
(Pull-down)
(none)
Afghanistan(AFG)
Albania(ALB)
Algeria(DZA)
American Samoa(ASM)
Andorra(AND)
Angola(AGO)
Anguilla(AIA)
Antarctica(ATA)
Antigua And Barbuda(ATG)
Argentina(ARG)
Armenia(ARM)
Aruba(ABW)
Australia(AUS)
Austria(AUT)
Azerbaijan(AZE)
Bahamas(BHS)
Bahrain(BHR)
Bangladesh(BGD)
Barbados(BRB)
Belarus(BLR)
Belgium(BEL)
Belize(BLZ)
Benin(BEN)
Bermuda(BMU)
Bhutan(BTN)
Bolivia(BOL)
Bosnia and Herzegovina(BIH)
Botswana(BWA)
Bouvet Island(BVT)
Brazil(BRA)
British Indian Ocean Territory(IOT)
Brunei Darussalam(BRN)
Bulgaria(BGR)
Burkina Faso(BFA)
Burundi(BDI)
Cambodia(KHM)
Cameroon(CMR)
Canada(CAN)
Cape Verde(CPV)
Cayman Islands(CYM)
Central African Republic(CAF)
Chad(TCD)
Chile(CHL)
China(CHN)
Christmas Island(CXR)
Cocos (Keeling) Islands(CCK)
Colombia(COL)
Comoros(COM)
Congo, the Democratic Republic of the(COD)
Cook Islands(COK)
Costa Rica(CRI)
Cote d'Ivoire(CIV)
Croatia (Hrvatska)(HRV)
Cuba(CUB)
Cyprus(CYP)
Czech Republic(CZE)
Denmark(DNK)
Djibouti(DJI)
Dominica(DMA)
Dominican Republic(DOM)
Ecuador(ECU)
Egypt(EGY)
El Salvador(SLV)
Equatorial Guinea(GNQ)
Eritrea(ERI)
Estonia(EST)
Ethiopia(ETH)
Falkland Islands (Malvinas)(FLK)
Faroe Islands(FRO)
Fiji(FJI)
Finland(FIN)
France(FRA)
French Guiana(GUF)
French Polynesia(PYF)
French Southern Territories(ATF)
Gabon(GAB)
Gambia(GMB)
Georgia(GEO)
Germany(DEU)
Ghana(GHA)
Gibraltar(GIB)
Greece(GRC)
Greenland(GRL)
Grenada(GRD)
Guadeloupe(GLP)
Guam(GUM)
Guatemala(GTM)
Guinea(GIN)
Guinea-Bissau(GNB)
Guyana(GUY)
Haiti(HTI)
Heard Island and McDonald Islands(HMD)
Holy See (Vatican City State)(VAT)
Honduras(HND)
Hong Kong(HKG)
Hungary(HUN)
Iceland(ISL)
India(IND)
Indonesia(IDN)
Iran, Islamic Republic of(IRN)
Iraq(IRQ)
Ireland(IRL)
Israel(ISR)
Italy(ITA)
Jamaica(JAM)
Japan(JPN)
Jordan(JOR)
Kazakhstan(KAZ)
Kenya(KEN)
Kiribati(KIR)
Korea, Democratic People's Republic of(PRK)
Korea, Republic of(KOR)
Kuwait(KWT)
Kyrgyzstan(KGZ)
Lao People's Democratic Republic(LAO)
Latvia(LVA)
Lebanon(LBN)
Lesotho(LSO)
Liberia(LBR)
Libyan Arab Jamahiriya(LBY)
Liechtenstein(LIE)
Lithuania(LTU)
Luxembourg(LUX)
Macao(MAC)
Macedonia, former Yugoslav Republic of(MKD)
Madagascar(MDG)
Malawi(MWI)
Malaysia(MYS)
Maldives(MDV)
Mali(MLI)
Malta(MLT)
Marshall Islands(MHL)
Martinique(MTQ)
Mauritania(MRT)
Mauritius(MUS)
Mayotte(MYT)
Mexico(MEX)
Micronesia, Federated States of(FSM)
Moldova, Republic of(MDA)
Monaco(MCO)
Mongolia(MNG)
Montenegro(MNE)
Montserrat(MSR)
Morocco(MAR)
Mozambique(MOZ)
Myanmar(MMR)
Namibia(NAM)
Nauru(NRU)
Nepal(NPL)
Netherlands Antilles(ANT)
Netherlands(NLD)
New Caledonia(NCL)
New Zealand(NZL)
Nicaragua(NIC)
Niger(NER)
Nigeria(NGA)
Niue(NIU)
Norfolk Island(NFK)
Northern Mariana Islands(MNP)
Norway(NOR)
Oman(OMN)
Pakistan(PAK)
Palau(PLW)
Palestine Territories(PSE)
Panama(PAN)
Papua New Guinea(PNG)
Paraguay(PRY)
Peru(PER)
Philippines(PHL)
Pitcairn(PCN)
Poland(POL)
Portugal(PRT)
Puerto Rico(PRI)
Qatar(QAT)
Reunion(REU)
Romania(ROU)
Russian Federation(RUS)
Rwanda(RWA)
Saint Helena(SHN)
Saint Kitts And Nevis(KNA)
Saint Lucia(LCA)
Saint Pierre and Miquelon(SPM)
Saint Vincent and the Grenadines(VCT)
Samoa(WSM)
San Marino(SMR)
Sao Tome And Principe(STP)
Saudi Arabia(SAU)
Senegal(SEN)
Serbia(SRB)
Seychelles(SYC)
Sierra Leone(SLE)
Singapore(SGP)
Slovakia(SVK)
Slovenia(SVN)
Solomon Islands(SLB)
Somalia(SOM)
South Africa(ZAF)
South Georgia and South Sandwich Islands(SGS)
Spain(ESP)
Sri Lanka(LKA)
Sudan(SDN)
Suriname(SUR)
Svalbard and Jan Mayen(SJM)
Swaziland(SWZ)
Sweden(SWE)
Switzerland(CHE)
Syrian Arab Republic(SYR)
Taiwan(TWN)
Tajikistan(TJK)
Tanzania, United Republic of(TZA)
Thailand(THA)
Timor-Leste(TLS)
Togo(TGO)
Tokelau(TKL)
Tonga(TON)
Trinidad And Tobago(TTO)
Tunisia(TUN)
Turkey(TUR)
Turkmenistan(TKM)
Turks And Caicos Islands(TCA)
Tuvalu(TUV)
Uganda(UGA)
Ukraine(UKR)
United Arab Emirates(ARE)
United Kingdom(GBR)
United States Minor Outlying Islands(UMI)
United States(USA)
Uruguay(URY)
Uzbekistan(UZB)
Vanuatu(VUT)
Venezuela, Bolivarian Republic of(VEN)
Vietnam(VNM)
Virgin Islands, British(VGB)
Virgin Islands, U.S.(VIR)
Wallis and Futuna(WLF)
Western Sahara(ESH)
Yemen(YEM)
Zambia(ZMB)
Zimbabwe(ZWE)
Category of inquiry 1 (multiple answers)
Pharmaceuticals
Medical devices (incld. in vitro diagnostics)
Others
Category of inquiry 2 (multiple answers)
Laws, regulations and guidance
Application for marketing authorization
Drug Master Files
Pharmacopoeia
Clinical trials/GCP
GLP
GMP/QMS
Accreditation of foreign manufacturers
Product safety
Products and materials
Manufacturers/Marketing authorization holders
Training
Communication
Comments to PMDA
Others
Subject (required)
Inquiry content (required)
Note: This form may not be sent if you use a line break in the text, so please don’t insert line breaks.